| P50 | author | Sherri-Ann M Burnett-Bowie | Q56523511 |
| P2093 | author name string | Joel S Finkelstein | |
| | Benjamin Z Leder | |
| | Douglas L Hayden | |
| | Maria P Henao | |
| | Chantel M Baldwin | |
| P2860 | cites work | Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 |
| | FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis | Q24319751 |
| | Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations | Q24595718 |
| | Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D | Q24655075 |
| | Vitamin D deficiency | Q27860616 |
| | Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production | Q28213962 |
| | Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo | Q28572995 |
| | A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 |
| | Prediction of creatinine clearance from serum creatinine | Q29615603 |
| | Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis | Q33932297 |
| | The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. | Q34022484 |
| | Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. | Q34067652 |
| | Vitamin D(3) is more potent than vitamin D(2) in humans | Q34156152 |
| | Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial | Q34175166 |
| | FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting | Q34227442 |
| | Vitamin D2 is much less effective than vitamin D3 in humans | Q34365889 |
| | FGF-23: More than a regulator of renal phosphate handling? | Q35156017 |
| | Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study | Q35664606 |
| | Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. | Q35728669 |
| | Dose response to vitamin D supplementation among postmenopausal African American women | Q36969247 |
| | Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. | Q42493065 |
| | Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. | Q42685427 |
| | Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term. | Q42928547 |
| | A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D. | Q42960410 |
| | Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women | Q43571607 |
| | Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice | Q44142771 |
| | Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia | Q44414604 |
| | Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial | Q44961452 |
| | Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. | Q45197408 |
| | Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells | Q45238632 |
| | Daily supplementation with 25 μg cholecalciferol does not increase calcium absorption or skeletal retention in adolescent girls with low serum 25-hydroxyvitamin D. | Q45928742 |
| | K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease | Q46286369 |
| | Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. | Q46585248 |
| | A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis | Q46609225 |
| | Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. | Q46680438 |
| | Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D. | Q46761922 |
| | Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism | Q46871114 |
| | Wintertime vitamin D supplementation inhibits seasonal variation of calcitropic hormones and maintains bone turnover in healthy men. | Q51439404 |
| | FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. | Q51480808 |
| | Vitamin D supplementation in postmenopausal black women. | Q51559884 |
| | FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. | Q53189719 |
| | Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. | Q55052329 |
| | The Effect of Vitamin D Supplementation on Vitamin D Status and Parathyroid Function in Elderly Subjects* | Q68506994 |
| | Vitamin D supplementation in elderly nursing home residents increases 25(OH)D but not 1,25(OH)2D | Q68924618 |
| | Calcium absorptive effects of vitamin D and its major metabolites | Q73941287 |
| | Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D | Q73956703 |
| | Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women | Q79995263 |
| | Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism | Q81251002 |
| P433 | issue | 4 | |
| P921 | main subject | ergocalciferol | Q139200 |
| P304 | page(s) | 624-631 | |
| P577 | publication date | 2012-02-02 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23 | |
| P478 | volume | 7 | |